Contrast agents for MRI: 30+ years and where are we going?
about
Basic MR relaxation mechanisms and contrast agent designBiodistribution and PET Imaging of pharmacokinetics of manganese in mice using Manganese-52Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.The reliability of parameters obtained by fitting of (1)H NMRD profiles and (17)O NMR data of potential Gd(3+)-based MRI contrast agents.Optical and relaxometric properties of monometallic (Eu(III), Tb(III), Gd(III)) and heterobimetallic (Re(I)/Gd(III)) systems based on a functionalized bipyridine-containing acyclic ligand.Normal saline as a natural intravascular contrast agent for dynamic perfusion-weighted MRI of the brain: Proof of concept at 1.5T.Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptidesAqueous Lanthanide Chemistry in Asymmetric Catalysis and Magnetic Resonance Imaging.Evaluation of Eu(II) -based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections.Gd(III)-Gold Nanoconjugates Provide Remarkable Cell Labeling for High Field Magnetic Resonance Imaging.Visualizing the atherosclerotic plaque: a chemical perspective.Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications.Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.Spectroscopic Characterization of the 3+ and 2+ Oxidation States of Europium in a Macrocyclic Tetraglycinate Complex.Ferritin heavy chain as a molecular imaging reporter gene in glioma xenografts.Gadolinium-Loaded Viral Capsids as Magnetic Resonance Imaging Contrast Agents.A scale to measure MRI contrast agent sensitivity.Paramagnetic relaxation based biosensor for selective dopamine detection.A new heptadentate picolinate-based ligand and its corresponding Gd(iii) complex: the effect of pendant picolinate versus acetate on complex properties.Toward inert paramagnetic Ni(ii)-based chemical exchange saturation transfer MRI agents.Challenges and opportunities in developing targeted molecular imaging to determine inner ear defects of sensorineural hearing loss.Nanoparticle-based highly sensitive MRI contrast agents with enhanced relaxivity in reductive milieu.MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.Multimodality reporter gene imaging: Construction strategies and application.Synthesis, Characterization, and Handling of EuII-Containing Complexes for Molecular Imaging Applications.A novel nitroreductase-enhanced MRI contrast agent and its potential application in bacterial imaging.Functional biomedical hydrogels for in vivo imaging
P2860
Q27692546-FA45776A-99ED-44AC-B70A-F2C1FFCAB9EBQ29248656-6DACC031-3090-4195-B3E7-AD462A6FD0A7Q30276990-11C1D91F-DE28-494E-86C3-71F44ABB45D3Q31048535-406A062B-E3C5-4183-9A10-73DF4899F728Q31067818-24C9E75D-AF51-4209-84EF-C2E60531C950Q31083784-54FFBB8C-3459-412C-87E7-5AFA63C8CE7CQ31086314-B9C080F5-04FB-47B1-942A-50FB1465AE37Q34196969-417C1E25-D124-4A88-A073-A93E0D0164D3Q37143146-06AEFA50-F736-42B9-8389-A469A48F3E7FQ37143467-A96A4BB9-A7F4-4D80-9D74-C41E93BC817FQ37592465-18F47D99-3F67-4044-A0C5-D95EFFC0FCBAQ38187881-CB5B78AB-3987-4DEE-B065-9D0C0D5EE839Q38637213-6422052D-199F-432D-8AC5-5042BEF4BAD0Q38809792-A20671E1-2E91-4473-97CA-B77ED6F67013Q39722949-2DA69AE7-EBE4-46F2-A73E-EA6600FDFEBBQ40313711-9481C1C7-16E0-4854-B636-A1152D7EEC05Q42379549-302A86D4-7E2A-4F66-98A5-46541B3B4E97Q43496696-BC55BBFF-F2A3-4226-9D0A-98428A4CDF47Q46713282-D71BCE55-0374-420B-9B2E-4DF53ACFA4D7Q47756394-FBB35D87-5444-42C8-916A-08B4E821F015Q50079199-04720389-6C4D-40A3-AA04-4D186F90BDA3Q50091564-46E14239-421D-4096-AC4B-84F2202E0E6FQ51242012-F7FF3E29-ADCA-470A-AC81-DE39AB3319E1Q52974826-64C354AB-62B3-4BA6-B701-DE260B569E32Q55046163-6D7C4D11-A916-4A15-8B22-75903AFF8A0FQ55069856-00EB185A-8751-4E7B-9D7F-42739F0A9050Q55153833-27D687E0-3EEE-49BF-B203-B749CB042400Q57377309-72105307-C659-4610-BFA2-AEC1A24403F9
P2860
Contrast agents for MRI: 30+ years and where are we going?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Contrast agents for MRI: 30+ years and where are we going?
@ast
Contrast agents for MRI: 30+ years and where are we going?
@en
type
label
Contrast agents for MRI: 30+ years and where are we going?
@ast
Contrast agents for MRI: 30+ years and where are we going?
@en
prefLabel
Contrast agents for MRI: 30+ years and where are we going?
@ast
Contrast agents for MRI: 30+ years and where are we going?
@en
P2860
P1476
Contrast agents for MRI: 30+ years and where are we going?
@en
P2093
Matthew J Allen
P2860
P2888
P304
P356
10.1007/S00775-013-1074-5
P577
2014-01-11T00:00:00Z